A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle

[1]  Matthew W. Strobeck,et al.  Compensation of BRG-1 Function by Brm , 2002, The Journal of Biological Chemistry.

[2]  M. Yaniv,et al.  SWI/SNF chromatin remodeling and cancer. , 2002, Current opinion in genetics & development.

[3]  G. Kalpana,et al.  A masked NES in INI1/hSNF5 mediates hCRM1‐dependent nuclear export: implications for tumorigenesis , 2002, The EMBO journal.

[4]  A. Turnell,et al.  Adenovirus E1A: remodelling the host cell, a life or death experience , 2001, Oncogene.

[5]  O. Delattre,et al.  Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression , 2001, Oncogene.

[6]  A. Sands,et al.  Disruption of Ini1 Leads to Peri-Implantation Lethality and Tumorigenesis in Mice , 2001, Molecular and Cellular Biology.

[7]  C. Roberts,et al.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Yaniv,et al.  The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression , 2000, EMBO reports.

[9]  Weidong Wang,et al.  A Specificity and Targeting Subunit of a Human SWI/SNF Family-Related Chromatin-Remodeling Complex , 2000, Molecular and Cellular Biology.

[10]  F Randazzo,et al.  A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. , 2000, Molecular cell.

[11]  P. Sudarsanam,et al.  The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. , 2000, Trends in genetics : TIG.

[12]  Matthew W. Strobeck,et al.  BRG-1 is required for RB-mediated cell cycle arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  O. Delattre,et al.  Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. , 2000, Journal of the National Cancer Institute.

[14]  J. Drake,et al.  Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. , 2000, American journal of human genetics.

[15]  Duanduan Ma,et al.  Exit from G1 and S Phase of the Cell Cycle Is Regulated by Repressor Complexes Containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF , 2000, Cell.

[16]  Weidong Wang,et al.  Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors , 1999, Oncogene.

[17]  K. Hoang-Xuan,et al.  Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. , 1999, Human molecular genetics.

[18]  O. Delattre,et al.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. , 1999, American journal of human genetics.

[19]  J. Harbour,et al.  Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.

[20]  R. Kingston,et al.  ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. , 1999, Genes & development.

[21]  R. Kingston,et al.  Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. , 1999, Molecular cell.

[22]  E. Lees,et al.  Cyclin E Associates with BAF155 and BRG1, Components of the Mammalian SWI-SNF Complex, and Alters the Ability of BRG1 To Induce Growth Arrest , 1999, Molecular and Cellular Biology.

[23]  M. Kirschner,et al.  Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. , 1998, Genes & development.

[24]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[25]  Robert A. Weinberg,et al.  Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes , 1998, Molecular and Cellular Biology.

[26]  S. Srivastava,et al.  Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells , 1998, Oncogene.

[27]  D. Trouche,et al.  RB and hbrm cooperate to repress the activation functions of E2F1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Yaniv,et al.  Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex. , 1996, The EMBO journal.

[29]  Guha,et al.  Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins , 1996, Molecular and cellular biology.

[30]  D. Trouche,et al.  E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Sellers,et al.  Interaction between the retinoblastoma protein and the oncoprotein MDM2 , 1995, Nature.

[32]  C. Sardet,et al.  A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. , 1995, Nucleic acids research.

[33]  G. Crabtree,et al.  Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. , 1994, Science.

[34]  Sushovan Guha,et al.  The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest , 1994, Cell.

[35]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[36]  B. Gallie,et al.  Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. , 1992, Molecular and cellular biology.

[37]  H. Magdelenat,et al.  Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation. , 1991, British Journal of Cancer.

[38]  A. Chobanian,et al.  Isoform-specific modulation of Na+, K+-ATPase alpha-subunit gene expression in hypertension. , 1988, Science.

[39]  J. Biegel,et al.  Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. , 1999, Cancer research.

[40]  W. Lee,et al.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.